Table of Contents Table of Contents
Previous Page  1636 / 1726 Next Page
Information
Show Menu
Previous Page 1636 / 1726 Next Page
Page Background

morbidity 3y ≥G3:

10%

3%

LC 3 y:

90%

OS 3 y:

IGABT/ChTh: 79%

NOCECA:

63%

Lindegaard et al.

Acta Oncologica 2013